46 page 1 stanford university criteria for irb approval of research gui 40 research compliance office 45 cfr 46.111 ohrp file gui03040 rev1 04 08 1 of 1 45 cfr 46.111 a in order to approve research covered by this policy the irb shall determine that all of the following requirements are satisfied risks to subjects are minimized eprotocol 2 a b 8 c f 9 c 1 risks to subjects are minimized i by using procedures which are consistent with sound research design and which do not unnecessarily expose subjects to risk and ii whenever appropriate by using procedures already being performed on the subjects for diagnostic or treatment purposes risks to subjects are reasonable in relation to anticipated benefits eprotocol 1 10 2 risks to subjects are reasonable in relation to anticipated benefits if any to subjects and the importance of the knowledge that may reasonably be expected to result in evaluating risks and benefits the irb should consider only those risks and benefits that may result from the research as distinguished from risks and benefits of therapies subjects would receive even if not participating in the research the irb should not consider possible long range effects of applying knowledge gained in the research for example the possible effects of the research on public policy as among those research risks that fall within the purview of its responsibility selection of subjects is equitable eprotocol 2 a b 8 c f 9 c 3 selection of subjects is equitable in making this assessment the irb should take into account the purposes of the research and the setting in which the research will be conducted and should be particularly cognizant of the special problems of research involving vulnerable populations such as children prisoners pregnant women mentally disabled persons or economically or educationally disadvantaged persons informed consent will be sought from each prospective subject eprotocol 13 4 informed consent will be sought from each prospective subject or the subject's legally authorized representative in accordance with and to the extent required by 46.116 informed consent will be appropriately documented eprotocol 13 5 informed consent will be appropriately documented in accordance with and to the extent required by 46.117 and when appropriate data collection is monitored to ensure subject safety eprotocol 9 e 6 when appropriate the research plan makes adequate provision for monitoring the data collected to ensure the safety of subjects privacy of subjects and confidentiality of data is protected eprotocol 11 7 when appropriate there are adequate provisions to protect the privacy of subjects and to maintain the confidentiality of data additional safeguards are included for vulnerable populations eprotocol 9 f 46.111 b when some or all of the subjects are likely to be vulnerable to coercion or undue influence such as children prisoners pregnant women mentally disabled persons or economically or educationally disadvantaged persons additional safeguards have been included in the study to protect the rights and welfare of these subjects fda regulated research only fda includes handicapped in the list of vulnerable subjects see also 21 cfr 56.111 a b c fda
